Filing summary
Important entity distinction: Although the request identifies Better Home & Finance Holding Co., the supplied Form 10-Q is filed by Aurora Acquisition Corp., its SPAC merger partner. The figures below are Aurora’s standalone pre-combination financial results, not Better’s operating results. The reporting period ended June 30, 2023; the filing was signed August 4, 2023.
Business context and reporting period
Aurora is a blank-check company with no operating revenue, formed to combine with Better HoldCo, Inc. The proposed merger had not closed by June 30, 2023. The parties extended the merger agreement and Aurora’s business-combination deadline to September 30, 2023. If the deadline is not extended and a combination is not completed, Aurora must wind up and redeem eligible shares.
Financial metrics
| Metric | Three months ended June 30, 2023 | Six months ended June 30, 2023 |
|---|---|---|
| Operating revenue | None | None |
| Formation and operating costs | $1.84 million | $3.67 million |
| Net income (loss) | $(0.83) million | $(0.96) million |
| Net income (loss) per share | $(0.09) | $(0.06) |
| Trust-account interest income | $0.19 million | $2.16 million |
| Operating cash flow | Not separately reported quarterly | $3.34 million provided |
Quarterly results also included a $560,368 gain from extinguishment of a liability after a vendor and legal adviser agreed to reduce fees. The six-month change in warrant fair value was an $8,089 loss; warrant remeasurement can cause earnings volatility. The filing reports no operating margins because Aurora had no operating revenue.
At June 30, 2023, Aurora reported $23.87 million in total assets, including $21.32 million in the trust account and $1.23 million of cash outside the trust. Current liabilities were $20.27 million, total liabilities $20.75 million, and shareholders’ equity $0.92 million. Working capital deficit was $17.71 million. Related-party loans outstanding were $412,395; a $16.25 million deferred credit liability was also recorded. The trust funds had been moved to cash and were expected to earn minimal, if any, interest.
Changes versus the prior comparable period
For Q2 2022 Aurora reported $1.79 million of net income, versus a $0.83 million loss in Q2 2023. The prior-year quarter included a $3.81 million gain from warrant remeasurement; Q2 2023 included a smaller $253,138 gain. Operating costs declined to $1.84 million from $2.63 million, while trust interest fell to $192,302 from $420,489. The 2023 quarter also included the $560,368 liability-extinguishment gain.
For the first six months, Aurora moved from $2.80 million net income in 2022 to a $0.96 million net loss in 2023. Trust interest rose to $2.16 million from $443,751, but the prior-year period benefited from a $5.89 million warrant fair-value gain. Cash outside the trust increased to $1.23 million from $285,307 at year-end 2022. In February 2023, redemptions released $263.12 million from the trust; 24,087,689 public shares and 1,663,760 Sponsor shares were redeemed.
Outlook, risks, and unusual items
- Combination deadline and going concern: Management disclosed substantial doubt about Aurora’s ability to continue as a going concern because of the September 30, 2023 mandatory liquidation date, absent a completed combination or approved extension. Management nevertheless stated it believed available capital would support operations through the earlier of a combination or one year from the filing date.
- Financing and dilution: Better had issued $750 million of pre-closing bridge notes to investors including SoftBank’s SB Northstar LP ($650 million) and Aurora’s Sponsor ($100 million). The notes have different conversion outcomes depending on whether the merger closes or terminates. The Sponsor also had options, subject to required Better approvals, for conversion at a 50% or 75% discount to a stated $6.9 billion pre-money valuation. These terms may have significant dilution and governance implications.
- Better reimbursements: Better had paid or transferred the agreed $15 million transaction-expense reimbursement. A separate $1.25 million regulatory-expense reimbursement due June 1 remained unpaid at quarter-end and was recorded as a receivable; another tranche was due September 1.
- Nasdaq listing: Aurora received notices for failure to meet the public-float requirement and the $35 million market-value standard. It had until October 3, 2023 to file specified ownership information for the public-float matter and until December 18, 2023 to regain compliance with the market-value standard. Delisting remained a risk.
- Controls and restatements: Management concluded disclosure controls were ineffective due to material weaknesses in accounting for complex instruments and unusual transactions, and in reconciliations of related-party expenses and accounts payable. Prior annual and quarterly financial statements were restated in April 2023. Remediation was ongoing, with no assurance it would be effective.
- Legal and regulatory: SEC staff informed Aurora and Better on August 3, 2023 that its investigation was concluded and it did not intend to recommend enforcement action. Earlier stockholder demand letters alleged omissions in merger disclosures, but no lawsuits had been filed in connection with those letters; a separate 2021 lawsuit was settled and dismissed.
- Other: Aurora liquidated trust investments into cash in February 2023, reducing expected interest income. The filing describes no formal operating-company guidance or forecast.
Important facts for investors to verify
- Confirm the merger’s status, closing conditions, and any extension beyond September 30, 2023; this filing does not report a completed transaction.
- Review the post-redemption trust balance, redemption mechanics, and the impact of further shareholder redemptions on funding and ownership.
- Verify the status and conversion terms of the $750 million Better bridge notes, including required approvals and potential dilution.
- Check whether Better paid the overdue $1.25 million reimbursement and the later regulatory-expense tranche.
- Track Nasdaq compliance, including the October 3 filing requirement and December 18 market-value deadline.
- Assess remediation of the disclosed material weaknesses and the consequences of the prior restatements.